This inventor holds 1 USPTO granted patent. Top assignees: Shandong Academy of Pharmaceutical Sciences, Shandong Freda Pharmaceutical Group Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovator in Joint Injections: The Journey of Qixin Chen
Introduction: Qixin Chen, an accomplished inventor from Jinan, China, has made significant contributions in the field of pharmaceutical sciences. His innovative approach has led to the development of a unique joint cavity injection preparation, showcasing his dedication to improving medical treatments.
Latest Patents: Qixin Chen holds a notable patent entitled "Joint Cavity Injection Preparation and Use Thereof." This invention revolves around a joint cavity injection preparation that utilizes deacetylated xanthan gum (XG) as its active ingredient. The deacetylated XG, with a molecular weight ranging from 500,000 to 20,000,000, demonstrates superior biocompatibility and a safer wide-dosage range compared to existing joint cavity injection preparations. This advancement not only emphasizes his innovative spirit but also highlights the potential for enhanced patient outcomes.
Career Highlights: Throughout his career, Chen has made impactful strides in pharmaceutical sciences. His affiliations with reputable organizations, such as the Shandong Academy of Pharmaceutical Sciences and Shandong Freda Pharmaceutical Group Co., Ltd., have further solidified his reputation as a leading inventor in his field.
Collaborations: Qixin Chen has worked alongside esteemed colleagues, including Peixue Ling and Fei Liu. These collaborations reflect the importance of teamwork in driving innovative solutions and advancing medical technology.
Conclusion: Qixin Chen exemplifies the spirit of innovation through his groundbreaking work in joint cavity injection preparations. His contributions, particularly in enhancing the safety and efficacy of joint treatments, are a testament to his commitment to improving healthcare solutions. As his career progresses, the impact of his inventions is likely to resonate in the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile